These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 22619522
21. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Drake EN. Med Hypotheses; 2006; 67(2):318-22. PubMed ID: 16574336 [Abstract] [Full Text] [Related]
22. Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. de Pace RC, Liu X, Sun M, Nie S, Zhang J, Cai Q, Gao W, Pan X, Fan Z, Wang S. J Liposome Res; 2013 Sep; 23(3):187-96. PubMed ID: 23600473 [Abstract] [Full Text] [Related]
23. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells. Sanna V, Pintus G, Roggio AM, Punzoni S, Posadino AM, Arca A, Marceddu S, Bandiera P, Uzzau S, Sechi M. J Med Chem; 2011 Mar 10; 54(5):1321-32. PubMed ID: 21306166 [Abstract] [Full Text] [Related]
24. Resveratrol nanoformulation for cancer prevention and therapy. Siddiqui IA, Sanna V, Ahmad N, Sechi M, Mukhtar H. Ann N Y Acad Sci; 2015 Aug 10; 1348(1):20-31. PubMed ID: 26109073 [Abstract] [Full Text] [Related]
25. Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems. Krupkova O, Ferguson SJ, Wuertz-Kozak K. J Nutr Biochem; 2016 Nov 10; 37():1-12. PubMed ID: 27770867 [Abstract] [Full Text] [Related]
26. Epigallocatechin-3-gallate enhances key enzymatic activities of hepatic thioredoxin and glutathione systems in selenium-optimal mice but activates hepatic Nrf2 responses in selenium-deficient mice. Dong R, Wang D, Wang X, Zhang K, Chen P, Yang CS, Zhang J. Redox Biol; 2016 Dec 10; 10():221-232. PubMed ID: 27810737 [Abstract] [Full Text] [Related]
27. Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy. Siddiqui IA, Sanna V. Mol Nutr Food Res; 2016 Jun 10; 60(6):1330-41. PubMed ID: 26935239 [Abstract] [Full Text] [Related]
28. Chemopreventive effect of epigallocatechin-3-gallate (EGCG) and folic acid on the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced gastrointestinal cancer in rat model. Xu Q, Yang CH, Liu Q, Jin XF, Xu XT, Tong JL, Xiao SD, Ran ZH. J Dig Dis; 2011 Jun 10; 12(3):181-7. PubMed ID: 21615871 [Abstract] [Full Text] [Related]
29. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery. Yang QQ, Wei XL, Fang YP, Gan RY, Wang M, Ge YY, Zhang D, Cheng LZ, Corke H. Crit Rev Food Sci Nutr; 2020 Jun 10; 60(8):1243-1264. PubMed ID: 30799648 [Abstract] [Full Text] [Related]
30. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS, Hara Y. Cancer Epidemiol Biomarkers Prev; 2001 Jan 10; 10(1):53-8. PubMed ID: 11205489 [Abstract] [Full Text] [Related]
31. Chemopreventive effect of aerosolized polyphenon E on lung tumorigenesis in A/J mice. Yan Y, Cook J, McQuillan J, Zhang G, Hitzman CJ, Wang Y, Wiedmann TS, You M. Neoplasia; 2007 May 10; 9(5):401-5. PubMed ID: 17534445 [Abstract] [Full Text] [Related]
32. EGCG-coated silver nanoparticles self-assemble with selenium nanowires for treatment of drug-resistant bacterial infections by generating ROS and disrupting biofilms. Yang C, Wang Z, Gao Y, Li M, Li Y, Dai C, Wang Y, Sun D. Nanotechnology; 2022 Jul 19; 33(41):. PubMed ID: 35777311 [Abstract] [Full Text] [Related]
33. Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture. Conney AH. Cancer Res; 2003 Nov 01; 63(21):7005-31. PubMed ID: 14612489 [Abstract] [Full Text] [Related]
34. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma. Singh M, Bhatnagar P, Mishra S, Kumar P, Shukla Y, Gupta KC. Int J Nanomedicine; 2015 Nov 01; 10():6789-809. PubMed ID: 26586942 [Abstract] [Full Text] [Related]
35. Chemoprevention of tobacco smoke-induced lung tumors by inhalation of an epigallocatechin gallate (EGCG) aerosol: a pilot study. Witschi H, Espiritu I, Ly M, Uyeminami D, Morin D, Raabe OG. Inhal Toxicol; 2004 Nov 01; 16(11-12):763-70. PubMed ID: 16036746 [Abstract] [Full Text] [Related]
38. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft. Kazi J, Sen R, Ganguly S, Jha T, Ganguly S, Chatterjee Debnath M. Int J Pharm; 2020 Jul 30; 585():119449. PubMed ID: 32464231 [Abstract] [Full Text] [Related]
39. (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia. Fang W, Peng ZL, Dai YJ, Wang DL, Huang P, Huang HP. Drug Deliv; 2019 Dec 30; 26(1):1058-1067. PubMed ID: 31735064 [Abstract] [Full Text] [Related]
40. Cytotoxicity and therapeutic effect of irinotecan combined with selenium nanoparticles. Gao F, Yuan Q, Gao L, Cai P, Zhu H, Liu R, Wang Y, Wei Y, Huang G, Liang J, Gao X. Biomaterials; 2014 Oct 30; 35(31):8854-8866. PubMed ID: 25064805 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]